Low molecular weight dextran amino acid injection

This product is a nutritional blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate already aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect, and this product has strong antigenicity. Since there are bacteria that produce this product in the normal intestine, some patients will have allergic reactions even after the first injection of this product. It is mainly an allergic reaction of the skin and mucous membranes. It can supplement the body's essential amino acids, significantly increase protein synthesis and improve nutritional status. It has the effects of promoting normal protein metabolism in the human body, correcting negative nitrogen balance, supplementing protein, and accelerating wound healing.

This product is a colorless or slightly yellowish, slightly viscous, clear sterile solution containing 6% low molecular weight dextran (average molecular weight of about M40,000) and 11 kinds of amino acids, containing 2.72% of total amino acids. Each 1ml contains 60mg of dextran, 2.72mg of total amino acids, and 4.2mg of effective nitrogen. The electrolyte concentration of this product is about 7mmol/L potassium ion and about 53mmol/L chloride ion. The pH value is 5.0-7.0. The osmotic pressure is about 300mOsm/L.

This product is a colorless or slightly yellowish, slightly viscous clear liquid, sometimes showing a slight opalescence.

It is used for various shock and thrombotic diseases. It can also be used for limb replantation and vascular surgery to prevent postoperative thrombosis.

Intravenous drip, 500 ml at a time, once a day, can be used continuously for 4 to 5 days or as directed by the doctor.

1. A small number of patients may experience allergic reactions, manifested as skin itching, urticaria, nausea, vomiting, asthma, cyanosis of the lips, collapse, a sharp drop in blood pressure, bronchospasm in severe cases, and some patients may even experience anaphylactic shock and even death. The incidence of allergic reactions is about 0.03% to 4.7%. People with allergic constitutions should undergo a skin test before use. 2. Fever, chills, swollen lymph nodes, arthritis, etc. are occasionally seen. 3. Bleeding tendency can cause coagulation disorders and prolong bleeding time. This reaction is often related to the dose. 4. Too fast an infusion rate can cause nausea, vomiting, headache and asthma.

It is contraindicated for patients with congestive heart failure and severe bleeding diseases. It is contraindicated for those who are allergic to this product.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Do not use it together with painkillers or epidural anesthesia during childbirth for prevention or treatment. If the mother is allergic to dextran or has an anaphylactic reaction, it may cause excessive uterine tension and fetal hypoxia. There is a risk of death or serious consequences to the infant's nervous system. Precautions for the elderly: Not yet clear.

1. When used in combination with heparin, the possibility of bleeding increases due to synergistic effects. 2. When used in combination with gentamicin and paromomycin, nephrotoxicity increases.

Keep tightly closed in a cool, dark and dry place.

250 ml contains 6.0% low molecular weight dextran and 2.72% total amino acids

Tentative 24 months

Livzon Pharmaceutical Grouping Limin Pharmaceutical FACTORY

• Founded in:

  1997-05-24

• Address:

  No. 89, Gongye West Road, Shaoguan City, Guangdong

• Tax NO.:

  91440200618357941C

• Registered Funds:

  61.56101 million yuan

• Email:

  Log in to view